Total Hip Arthroplasty for Osteonecrosis in Patients Under 50 years old is Associated with an Increased risk of post-surgical Complications
Original Article | Journal of Clinical Orthopaedics | Vol 10 | Issue 2 | July-December 2025 | page: 99-104 | Pradip Ramamurti, Corinne Vennitti, Shivam Gandhi, Quanjun Cui, Tracy Borsinger
DOI: https://doi.org/10.13107/jcorth.2025.v10.i02.790
Open Access License: CC BY-NC 4.0
Copyright Statement: Copyright © 2025; The Author(s).
Submitted Date: 22 Aug 2025, Review Date: 17 Sep 2025, Accepted Date: 28 Oct 2025 & Published Date: 10 Dec 2025
Author: Pradip Ramamurti [1], Corinne Vennitti [1], Shivam Gandhi [1], Quanjun Cui [1], Tracy Borsinger [1]
[1] University of Virginia, Department of Orthopaedic Surgery, 2280 Ivy Road, Charlottesville, VA 22903.
Address of Correspondence
Dr. Corinne Vennitti
University of Virginia, Department of Orthopaedic Surgery, 2280 Ivy Road, Charlottesville, VA 22903.
E-mail: CV3AJ@uvahealth.org
Abstract
Introduction: Osteonecrosis (ON) of the femoral head is responsible for roughly 2 to 10% of total hip arthroplasty (THA) indications. The purpose of this study is to compare complication rates for patients under 50 years old undergoing THA for ON versus osteoarthritis (OA).
Methods: Patients between the ages of 18- and 50-years old undergoing THA for ipsilateral osteonecrosis were identified in the PearlDiver database. A control cohort of patients between the same age thresholds were identified who underwent THA for osteoarthritis. Any patient with a history of proximal femur fracture or prior operative fixation of a proximal femur fracture was excluded. Patients were included if they had a 5-year postoperative database followed up after THA. The 90-day rates of post-operative medical and 5-year surgical complications were recorded. Multivariate analysis was conducted to account for confounding variables and covariates. Subgroup analyses were also performed stratified by age (<30, 30–40, and 40–50 years) to assess revision outcomes.
Results: A final cohort of 6,955 patients met inclusion criteria, 1,769 (25.4%) underwent THA for osteonecrosis while 5,186 (74.6%) underwent THA for OA. Patients undergoing THA for ON had a higher incidence of 5-year post-surgical instability (3.1% vs. 2.2%, OR 1.51, P=0.025) when compared to THA for OA. Similarly, those undergoing THA for OA had a higher incidence of 5-year revision (4.4% vs. 3.0%, OR 1.45, P=0.018) and 90-day readmission (8.0% vs. 4.4%, OR 1.41, P=0.006), and emergency department visits (18.4% vs. 11.1%, OR 1.33, P=0.001) when compared to those undergoing THA for OA.
Conclusion: Patients younger than 50 years old undergoing THA for ON experience increased post-surgical complications such as revision, dislocation, hospital readmission and emergency department visits compared to patients under 50 years old undergoing THA for OA. These findings provide insight for preoperative considerations for arthroplasty surgeons in this patient population.
Keywords: Hip osteoarthritis, Hip osteonecrosis, Total hip arthroplasty, Avascular necrosis, Implant survival, Clinical outcomes, Revision total hip arthroplasty
References
[1] Fontalis, Andreas et al. “Advances and innovations in total hip arthroplasty.” SICOT-J vol. 7 (2021): 26. doi:10.1051/sicotj/2021025
[2] Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007 Oct 27;370(9597):1508-19. doi: 10.1016/S0140-6736(07)60457-7. PMID: 17964352.
[3] Tripathy, Sujit Kumar et al. “Management of femoral head osteonecrosis: Current concepts.” Indian journal of orthopaedics vol. 49,1 (2015): 28-45. doi:10.4103/0019-5413.143911
[4] Hines, Jeremy T et al. “Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment.” Journal of Korean medical science vol. 36,24 e177. 21 Jun. 2021, doi:10.3346/jkms.2021.36.e177
[5] Mont, Michael A. MD1; Cherian, Jeffrey J. DO1; Sierra, Rafael J. MD2; Jones, Lynne C. PhD3; Lieberman, Jay R. MD4. Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A Ten-Year Update. The Journal of Bone and Joint Surgery 97(19):p 1604-1627, October 7, 2015. | DOI: 10.2106/JBJS.O.00071
[6] Birla, Vikas et al. “Risk factors and pathogenesis of steroid-induced osteonecrosis of femoral head – A scoping review.” Journal of clinical orthopaedics and trauma vol. 23 101643. 13 Oct. 2021, doi:10.1016/j.jcot.2021.101643
[7] Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T. Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol. 2007 Jul;63(1):16-28. doi: 10.1016/j.ejrad.2007.03.019. Epub 2007 Jun 6. PMID: 17555906.
[8] Konarski, Wojciech et al. “Avascular Necrosis of Femoral Head-Overview and Current State of the Art.” International journal of environmental research and public health vol. 19,12 7348. 15 Jun. 2022, doi:10.3390/ijerph19127348
[9] Wen, Zeqin et al. “Global Trends and Current Status in Osteonecrosis of the Femoral Head: A Bibliometric Analysis of Publications in the Last 30 Years.” Frontiers in endocrinology vol. 13 897439. 15 Jun. 2022, doi:10.3389/fendo.2022.897439
[10] Cardín-Pereda, Adrián et al. “Osteonecrosis of the Femoral Head: A Multidisciplinary Approach in Diagnostic Accuracy.” Diagnostics (Basel, Switzerland) vol. 12,7 1731. 16 Jul. 2022, doi:10.3390/diagnostics12071731
[11] Zhang, Z., Chi, J., Driskill, E., Mont, M., Jones, L. C., & Cui, Q. (2023). Effect of Patient Age on Total Hip Arthroplasty Outcomes in Patients Who Have Osteonecrosis of the Femoral Head Compared to Patients Who Have Hip Osteoarthritis. In The Journal of Arthroplasty. Elsevier BV. https://doi.org/10.1016/j.arth.2023.12.029
[12] Lavernia, Carlos J, and Jesus M Villa. “Total hip arthroplasty in the treatment of osteonecrosis of the femoral head: then and now.” Current reviews in musculoskeletal medicine vol. 8,3 (2015): 260-4. doi:10.1007/s12178-015-9290-y
[13] Mont, Michael A et al. “The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review.” The Journal of bone and joint surgery. American volume vol. 92,12 (2010): 2165-70. doi:10.2106/JBJS.I.00575
[14] Dima, Alina et al. “Association of common comorbidities with osteonecrosis: a nationwide population-based case-control study in Denmark.” BMJ open vol. 8,2 e020680. 8 Feb. 2018, doi:10.1136/bmjopen-2017-020680
[15] George, Gary, and Joseph M Lane. “Osteonecrosis of the Femoral Head.” Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews vol. 6,5 e21.00176. 1 May. 2022, doi:10.5435/JAAOSGlobal-D-21-00176
[16] Wei, Qijiao et al. “Symptomatic femoral head necrosis in patients with rheumatoid arthritis: A retrospective case-control study.” Immunity, inflammation and disease vol. 10,6 (2022): e633. doi:10.1002/iid3.633
[17] van Vollenhoven, Ronald F. “Sex differences in rheumatoid arthritis: more than meets the eye…” BMC medicine vol. 7 12. 30 Mar. 2009, doi:10.1186/1741-7015-7-12
[18] Goemaere, S et al. “Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition.” The Journal of rheumatology vol. 17,12 (1990): 1620-2.
[19] Dargel, Jens et al. “Dislocation following total hip replacement.” Deutsches Arzteblatt international vol. 111,51-52 (2014): 884-90. doi:10.3238/arztebl.2014.0884
[20] Salman, Loay A et al. “The outcomes of total hip replacement in osteonecrosis versus osteoarthritis: a systematic review and meta-analysis.” International orthopaedics vol. 47,12 (2023): 3043-3052. doi:10.1007/s00264-023-05761-6
[21] Yang, Scott et al. “Does osteonecrosis of the femoral head increase surgical and medical complication rates after total hip arthroplasty? A comprehensive analysis in the United States.” Hip international : the journal of clinical and experimental research on hip pathology and therapy vol. 25,3 (2015): 237-44. doi:10.5301/hipint.5000224
[22] Mallon, Charlotte et al. “Surgeons are deeply affected when patients are diagnosed with prosthetic joint infection.” PloS one vol. 13,11 e0207260. 28 Nov. 2018, doi:10.1371/journal.pone.0207260
[23] Cherian, Jeffrey J et al. “What Host Factors Affect Aseptic Loosening After THA and TKA?.” Clinical orthopaedics and related research vol. 473,8 (2015): 2700-9. doi:10.1007/s11999-015-4220-2
[24] Sax, Oliver C et al. “Osteoarthritis and Osteonecrosis in Total Hip Arthroplasty: 90-Day Postoperative Costs and Outcomes.” The Journal of arthroplasty vol. 36,7 (2021): 2343-2347. doi:10.1016/j.arth.2020.10.039
[25] Hoggard, Timothy M et al. “Outcomes Following Total Hip Arthroplasty for Osteonecrosis of the Femoral Head in Patients on Hemodialysis.” The Journal of bone and joint surgery. American volume vol. 104,Suppl 2 (2022): 90-94. doi:10.2106/JBJS.20.00352
[26] Alluri, Ram K et al. “Surgical research using national databases.” Annals of translational medicine vol. 4,20 (2016): 393. doi:10.21037/atm.2016.10.49
[27] Bolognesi MP, Habermann EB. Commercial Claims Data Sources: PearlDiver and Individual Payer Databases. JBJS 2022;104:15. https://doi.org/10.2106/JBJS.22.00607.
| How to Cite this Article: Ramamurti P, Vennitti C, Gandhi S, Cui Q, Borsinger T. Total Hip Arthroplasty for Osteonecrosis in Patients Under 50 years old is Associated with an Increased risk of post-surgical Complications. Journal of Clinical Orthopaedics. July-December 2025;10(2):99-104. |
(Article Text HTML) (Download PDF)



